Real-time enrollment status for this leptomeningeal disease (lmd) clinical trial
Current Status
Recruiting
Checked: September 11, 2026 at 9:25 PM UTC
| NCT Number | NCT07814352 |
| Recruiting Status | Recruiting |
| Condition | Leptomeningeal Disease (LMD) |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | September 11, 2026 (21 hours ago) |
As of September 11, 2026: Clinical trial NCT07814352 is currently recruiting participants. This phase1 study for leptomeningeal disease (lmd) is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07814352 is actively recruiting participants as of September 11, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07814352 was last updated 21 hours ago (September 11, 2026). HelloStudys verifies this status automatically.